High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome

Archives of Gynecology and Obstetrics

Volumn 281, Issue 6, 2010, Pages 1009-1014

  Verit, Fatma Ferda ^a  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cardiovascular risk; High sensitive serum C reactive protein; Insulin resistance; Metabolic syndrome; Polycystic ovary syndrome

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MODEL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; SPECTROPHOTOMETRY; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADOLESCENT; ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; METABOLIC SYNDROME X; OBESITY; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; WAIST-HIP RATIO; YOUNG ADULT;

EID: 77953651928     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1226-6     Document Type: Article

References (31)

1. DA Ehrmann 2005 Polycystic ovary syndrome N Engl J Med 352 1223 1236 10.1056/NEJMra041536 1:CAS:528:DC%2BD2MXisFShtL8%3D 15788499 (Pubitemid 40397264)
2. T Cascella S Palomba I De Sio F Manguso F Giallauria B De Simone D Tafuri G Lombardi A Colao F Orio 2008 Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome Hum Reprod 23 153 159 10.1093/humrep/dem356 1:CAS:528:DC%2BD2sXhsVWgsb3P 18024952 (Pubitemid 351767326)
3. S Bevc S Sabic R Hojs 2008 Atherosclerosis in hemodialysis patients: the role of microinflammation Ren Fail 30 1012 1016 10.1080/08860220802406385 1:CAS:528:DC%2BD1cXhtl2qurjL 19016154
4. I Ikonomidis K Stamatelopoulos J Lekakis GD Vamvakou DT Kremastinos 2008 Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease Atherosclerosis 199 3 11 10.1016/j.atherosclerosis.2008.02.019 1:CAS:528:DC%2BD1cXns1Snsbk%3D 18378239
5. GK Hansson 2009 Atherosclerosis, an immune disease: the Anitschkov lecture 2007 Atherosclerosis 202 2 10 10.1016/j.atherosclerosis.2008.08.039 1:CAS:528:DC%2BD1cXhsFajsb%2FP 18951547
6. CC Kelly H Lyall JR Petrie GW Gould JM Connell N Sattar 2001 Low-grade chronic inflammation in women with polycystic ovarian syndrome J Clin Endocrinol Metab 86 2453 2455 10.1210/jc.86.6.2453 1:CAS:528:DC%2BD3MXktlKitrc%3D 11397838 (Pubitemid 32545690)
7. R Thomann N Rossinelli U Keller BF Tirri C De Geyter J Ruiz M Kränzlin JJ Puder 2008 Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome Gynecol Endocrinol 24 199 206 10.1080/09513590801893398 1:CAS:528:DC%2BD1cXkt12jurk%3D 18382906 (Pubitemid 351481776)
8. M Fröhlich A Imhof G Berg WL Hutchinson MB Pepys H Boeing R Muche H Brenner W Koenig 2000 Association between C-reactive protein and features of the metabolic syndrome: a population-based study Diabetes Care 23 1835 1839 10.2337/diacare.23.12.1835 11128362
9. JJ Puder S Varga M Kraenzlin C De Geyter U Keller B Müller 2005 Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance J Clin Endocrinol Metab 90 6014 6021 10.1210/jc.2005-1002 1:CAS:528:DC%2BD2MXht1alt7nK 16105965 (Pubitemid 41606519)
10. F Giallauria F Orio S Palomba G Lombardi A Colao C Vigorito 2008 Cardiovascular risk in women with polycystic ovary syndrome J Cardiovasc Med (Hagerstown) 9 987 992
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19 25
12. D Ferriman JD Gallwey 1961 Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1440 1447 10.1210/jcem-21-11-1440 1:STN:280:DyaF38%2Fjtl2jtw%3D%3D 13892577
13. JP Baillargeon DJ Jakubowicz MJ Iuorno S Jakubowicz JE Nestler 2004 Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity Fertil Steril 82 893 902 10.1016/j.fertnstert.2004.02.127 1:CAS:528: DC%2BD2MXhvFOjtrY%3D 15482765 (Pubitemid 39346435)
14. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D 3899825 (Pubitemid 15018832)
15. FV Comim PM Spritzer 2004 Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome Fertil Steril 81 108 113 10.1016/j.fertnstert.2003.05.027 1:CAS:528: DC%2BD2MXitFCrs7Y%3D 14711552 (Pubitemid 38058334)
16. World Health Organization (1994) WHO study group prevention of diabetes mellitus. Technical report series 844. World Health Organization, Geneva
17. Expert Committee on the Diagnosis and Classification 2003 Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 3160 3167 10.2337/diacare.26.11.3160 (Pubitemid 37339514)
18. B Yildirim N Sabir B Kaleli 2003 Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome Fertil Steril 79 1358 1364 10.1016/S0015-0282(03)00265-6 12798883 (Pubitemid 36687882)
19. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr JA Spertus F Costa American Heart Association National Heart, Lung, Blood Institute 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
20. M Rizzo K Berneis G Spinas GB Rini E Carmina 2009 Long-term consequences of polycystic ovary syndrome on cardiovascular risk Fertil Steril 91 4 Suppl 1563 1567 10.1016/j.fertnstert.2008.09.070 18976752
21. E Anuurad RP Tracy TA Pearson K Kim L Berglund 2009 Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians Atherosclerosis 205 290 295 10.1016/j.atherosclerosis.2008.11.028 1:CAS:528:DC%2BD1MXnsFagu7s%3D 19135196
22. HF Escobar-Morreale G Villuendas JI Botella-Carretero J Sancho JL San Millán 2003 Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women Diabetologia 46 625 633 1:CAS:528:DC%2BD3sXksFKlsr4%3D 12739017
23. KJ Mather F Kwan B Corenblum 2000 Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity Fertil Steril 73 150 156 10.1016/S0015-0282(99)00468-9 1:STN:280: DC%2BD3c%2Fps1aqsA%3D%3D 10632431 (Pubitemid 30018040)
24. T Apridonidze PA Essah MJ Iuorno JE Nestler 2005 Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome J Clin Endocrinol Metab 90 1929 1935 10.1210/jc.2004-1045 1:CAS:528:DC%2BD2MXjsFWjtr8%3D 15623819 (Pubitemid 40586223)
25. M Möhlig J Spranger M Osterhoff M Ristow AF Pfeiffer T Schill HW Schlösser G Brabant C Schöfl 2004 The polycystic ovary syndrome per se is not associated with increased chronic inflammation Eur J Endocrinol 150 525 532 10.1530/eje.0.1500525 15080783 (Pubitemid 38584704)
26. Y Wu J Zhang Y Wen H Wang M Zhang K Cianflone 2009 Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome Fertil Steril 91 213 219 10.1016/j.fertnstert.2007.11.031 1:CAS:528:DC%2BD1MXnsF2nt7Y%3D 18206145
27. K Berneis M Rizzo M Hersberger GB Rini G Di Fede I Pepe GA Spinas E Carmina 2009 Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome Int J Clin Pract 63 56 62 10.1111/j.1742-1241.2008.01897.x 1:CAS:528:DC%2BC3cXktFGnsb0%3D 19125993
28. K Guzelmeric N Alkan M Pirimoglu O Unal C Turan 2007 Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome Gynecol Endocrinol 23 505 510 10.1080/09513590701554306 1:CAS:528:DC%2BD2sXhtFOjtLbO 17852421 (Pubitemid 47628538)
29. D König P Deibert K Winkler A Berg 2005 Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease Exerc Immunol Rev 11 97 107 16385847
30. N Boulman Y Levy R Leiba S Shachar R Linn O Zinder Z Blumenfeld 2004 Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease J Clin Endocrinol Metab 89 2160 2165 10.1210/jc.2003-031096 1:CAS:528:DC%2BD2cXjvFyrtrk%3D 15126536 (Pubitemid 38619847)
31. Kaya C, Pabuccu R, Berker B, Satiroglu H (2009) Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors. Fertil Steril [Epub ahead of print]